Sartorius Aktiengesellschaft (FRA:SRT4)

Market Cap	14.69B -0.7%
Revenue (ttm)	3.52B +5.8%
Net Income	133.60M +72.2%
EPS	n/a
Shares Out	n/a
PE Ratio	109.96
Forward PE	39.25
Dividend	0.08 (0.20%)
Ex-Dividend Date	Mar 31, 2025

Volume	n/a
Average Volume	n/a
Open	39.20
Previous Close	39.20
Day's Range	39.20 - 39.20
52-Week Range	29.00 - 44.00
Beta	n/a
RSI	43.69
Earnings Date	Feb 3, 2026

About FRA:SRT4

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 13,878
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SRT4

Financial Performance

In 2024, FRA:SRT4's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.